Howard Levy, Chief Medical Officer at CATALYST BIOSCIENCES, INC. (CBIO), bought 2,500 shares at $4.05 ($10K) on 2020-03-16, disclosed to the SEC on 2020-03-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CBIO | BUY | 2020-08-12 | $9K | — | Filing → |
| CBIO | SELL | 2018-11-16 | $2K | — | Filing → |